Brought to you by 
Thermo Fisher Scientific nets $1.5bn in FOPO
10 Jun 2021
Executive Summary
Thermo Fisher Scientific Inc. netted $1.5bn in a follow-on public offering through the sale of 8.8mm common shares at $171. The company will use the offering proceeds to pay for a portion of its acquisition of Patheon NV.
Deal Industry
- Laboratory Testing Services
- Research, Analytical Equipment & Supplies
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Thermo Fisher Scientific nets $1.5bn in FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice